Good morning :)
Place Order
Add to Watchlist

Indraprastha Medical Corporation Ltd

INDRAMEDCO

Indraprastha Medical Corporation Ltd

INDRAMEDCO
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,727 cr, stock is ranked 875
High RiskStock is 3.94x as volatile as Nifty
407.600.22% (+0.90)
407.600.22% (+0.90)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,727 cr, stock is ranked 875
High RiskStock is 3.94x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹3,727 cr, stock is ranked 875
High RiskStock is 3.94x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
25.227.801.11%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.446.570.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Indraprastha Medical Corporation Limited is engaged in healthcare business.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 2.15% to 2.04%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue757.57766.18753.45788.64831.46614.06891.281,108.701,261.591,339.20
Raw Materialssubtract0.000.000.000.000.000.000.000.000.001,092.37
Power & Fuel Costsubtract25.1620.9119.2619.7021.1617.1820.5625.2226.01
Employee Costsubtract181.56190.26194.01200.21213.93197.71213.92246.70261.61
Selling & Administrative Expensessubtract74.1076.5872.2978.2083.66186.62292.12405.34462.43
Operating & Other expensessubtract395.25399.17394.31409.28425.63171.60247.26270.71301.29
Depreciation/Amortizationsubtract35.3330.5330.6829.7532.9733.3234.9439.2740.0842.45
Interest & Other Itemssubtract7.427.918.906.875.923.343.414.284.065.63
Taxes & Other Itemssubtract14.3214.5712.9016.214.571.9620.4531.0342.1550.97
EPS2.662.862.303.104.760.256.399.4013.5216.12
DPS1.801.801.501.600.000.002.503.004.504.50
Payout ratio0.680.630.650.520.000.000.390.320.330.28

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Indraprastha Medical Corporation Ltd30.077.801.11%
Apollo Hospitals Enterprise Ltd112.3413.790.23%
Max Healthcare Institute Ltd93.5111.760.15%
Fortis Healthcare Ltd78.735.510.16%

Price Comparison

Compare INDRAMEDCO with any stock or ETF
Compare INDRAMEDCO with any stock or ETF
INDRAMEDCO
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.00%2.66%0.54%2.64%43.16%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%2.61%2.66%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 4 Mutual Funds holding Indraprastha Medical Corporation Ltd




Funds (Top 4)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Quant Small Cap Fund - Growth - Direct Plan

Growth
2.7477%0.38%0.21%101/110 (-11)
Motilal Oswal Quant Fund - Growth - Direct Plan

Growth
0.0487%1.19%1.19%76/138 (+14)
Bandhan BSE Healthcare Index Fund Direct Plan-Growth

Growth
0.0007%0.14%0.14%65/102 (-3)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 13, 2024

Final
Final | Div/Share: ₹4.50

Dividend/Share

4.50

Ex DateEx Date

Sep 13, 2024

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 15, 2023

Cash Dividend

Ex DateEx DateSep 15, 2022

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Sep 15, 2022

Cash Dividend

Ex DateEx DateSep 12, 2019

Final
Final | Div/Share: ₹1.60

Dividend/Share

1.60

Ex DateEx Date

Sep 12, 2019

Cash Dividend

Ex DateEx DateSep 12, 2018

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 12, 2018

News & Opinions
Earnings
Indraprastha Medical Corporation standalone net profit rises 29.07% in the September 2024 quarter

Net profit of Indraprastha Medical Corporation rose 29.07% to Rs 42.40 crore in the quarter ended September 2024 as against Rs 32.85 crore during the previous quarter ended September 2023. Sales rose 10.35% to Rs 349.82 crore in the quarter ended September 2024 as against Rs 317.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales349.82317.00 10 OPM %18.1915.89 - PBDT68.1053.68 27 PBT56.9343.65 30 NP42.4032.85 29 Powered by Capital Market - Live

2 days agoCapital Market - Live
Corporate
Indraprastha Medical Corporation announces board meeting date

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to hold AGM

Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 46.79% in the June 2024 quarter

Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to declare Quarterly Result

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Indraprastha Medical Corp hits 52-week high after HDFC Bank sells 27.8 lakh shares

6 months agoMoneycontrol

Khaitan (India) Ltd leads gainers in ‘B’ group

1 year agoBusiness Standard

Indraprastha Medical Corporation standalone net profit rises 108.03% in the September 2022 quarter

1 year agoBusiness Standard

Board of debt-free multibagger stock fixes record date for dividend

2 years agoLivemint

Indraprastha Medical Corporation reports standalone net profit of Rs 15.44 crore in the June 2021 quarter

3 years agoBusiness Standard